Delivery Order SPE2DB20D1100-SPE2DB22FY80A
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,874.29 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of JANUMET XR 50-1,000 mg tablets in 60-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,745.04 to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to provide JANUMET XR 50-1,000 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded by DLA to AmerisourceBergen Drug Corp, which serves as the prime contractor to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $42,641.11 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of Janumet XR 50-1,000 mg tablets in quantities of 180 per unit. The delivery order is part of a larger indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, valued at up to $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide JANUMET XR 50-1,000 MG tablets in 180-count bottles. The $23,816.02 award has a performance period through March 29, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,072,292 units of the pharmaceutical product JANUMET XR 50-1,000 mg tablets in 180-count packages. The total ceiling value of the contract is $2,687.00 with a period of performance through March 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp holds an Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply JANUMET XR 100-1,000 MG tablets. The contract has a potential value of $2,450.76 and a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a pharmaceutical and medical supply provider to the Department of Defense through multiple DLA contracts, including an indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of JANUMET XR 50-500 mg tablets. The $1,418.23 contract has a firm fixed price and an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide JANUMET XR 100-1,000 MG TABLET 90S. The $16,017.25 order was issued on May 18, 2022, with a completion date of May 19, 2022. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of JANUMET XR 100-1,000 mg tablets. The firm-fixed-price contract has a ceiling value of $5,883.42 and an ultimate completion date of April 18, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, leverages its extensive supply chain to fulfill government contracts, particularly for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of JANUMET 50-1,000 MG TABLET 180S. The contract has a ceiling value of $10,560.11 and a period of performance through April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of an indefinite delivery contract (IDC) valued at up to...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB22FY80ADelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of JANUMET XR 100-1,000 MG tablets, with a ceiling value of $1,667.78 and a performance period through November 16, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as Amerisourcebergen's primary contract vehicle for delivering pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 11/15/21 |